Vimarsana
Biggest News Aggregation in the World

Pascaline Clerc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pascaline Clerc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pascaline Clerc Today - Breaking & Trending Today

Inventiva announces two scientific presentations at the EASL International Liver Congress™ 2024 - Vimarsana News

Inventiva announces two scientific presentations at the EASL International Liver Congress™ 2024

The first abstract demonstrates that the improvements of MACK-3, a diagnostic test for metabolic dysfunction-associated steatohepatitis, parallel the histological response to lanifibranor therapy in...

INVENTIVA: Inventiva announces two scientific presentations at the EASL International Liver Congress 2024 - Vimarsana News

INVENTIVA: Inventiva announces two scientific presentations at the EASL International Liver Congress 2024

The first abstract demonstrates that the improvements of MACK-3, a diagnostic test for metabolic dysfunction-associated steatohepatitis, parallel the histological response to lanifibranor therapy in patients

Inventiva announces the positive recommendation of the fourth DMC of the NATiV3 Phase III clinical trial with lanifibranor in patients with MASH/NASH - Vimarsana News

Inventiva announces the positive recommendation of the fourth DMC of the NATiV3 Phase III clinical trial with lanifibranor in patients with MASH/NASH

The Data Monitoring Committee recommended to continue the clinical trial without modification of the current protocol, based on the pre-planned review of safety data.The recommendation was based on...

Inventiva announces filing of its 2023 Universal Registration Document and 2023 Annual Report on Form 20-F - Vimarsana News

Inventiva announces filing of its 2023 Universal Registration Document and 2023 Annual Report on Form 20-F

Daix , Long Island City , April 3, 2024 – Inventiva , a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of metabolic...

Inventiva reports its 2023 full-year results - Vimarsana News

Inventiva reports its 2023 full-year results

Revenues at €17.5 million for the full year of 2023 up 43.4% compared to €12.2 million for 2022 Cash and cash equivalents at €26.9 million, short-term deposits at €0.01 million1, and...